4.7 Article

COVID-19 Vaccination Status and Hesitancy among Breast Cancer Patients after Two Years of Pandemic: A Cross-Sectional Survey

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Attitude towards and perception of individual safety after SARS-CoV-2 vaccination among German cancer patients

Oliver Overheu et al.

Summary: Acceptance of SARS-CoV-2 vaccination is high among German cancer patients, but concerns about vaccine safety remain. Female patients are more afraid of COVID-19, while male patients have more dissenting opinions about the vaccine. Most patients report good tolerability after vaccination and are willing to receive it yearly.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Article Oncology

Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine

Rebecca M. Shulman et al.

Summary: This study aimed to record and compare short-term adverse reactions to COVID-19 vaccines in patients with and without cancer. The results showed that there were few differences in reported adverse events between cancer patients and non-cancer patients. Active cancer treatment had little impact on adverse event profiles.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

Article Biology

Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients

Giulia Di Felice et al.

Summary: This meta-analysis compares the outcomes of unvaccinated COVID-19 patients with and without cancer. The results indicate a twofold increased risk of adverse outcomes (mortality, ICU admission, and severity of COVID-19) in unvaccinated COVID-19 patients with cancer compared to COVID-19 patients without cancer. These findings emphasize the importance of preventing SARS-CoV-2 infection in patients with cancer.
Article Oncology

SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents

Charlotte Fenioux et al.

Summary: This study aimed to assess the immune humoral response to the BNT162b2 vaccine in patients treated with anticancer agents. The results showed that the majority of patients had a good humoral response 28 days after the second dose of vaccine, but it gradually decreased over time. The study also found that the time between vaccine and chemotherapy did not interfere with the humoral response.

JAMA ONCOLOGY (2022)

Article Integrative & Complementary Medicine

Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey

Jing Hong et al.

Summary: This study investigated the knowledge, attitude, acceptance, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China. The results showed that factors such as alcohol consumption, income impacted by the COVID-19 pandemic, knowledge of how the vaccine was developed, belief in the safety of the vaccine, willingness to pay for the vaccine, and willingness to recommend others to get vaccinated were associated with vaccine acceptance. On the other hand, factors such as being retired, undergoing multiple therapies of cancer, and worrying that the vaccine might deteriorate the prognosis of cancer were associated with vaccine hesitancy.

JOURNAL OF INTEGRATIVE MEDICINE-JIM (2022)

Article Public, Environmental & Occupational Health

COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Inter net-Based Survey

Richard Tsai et al.

Summary: This study investigated COVID-19 vaccine hesitancy and acceptance among individuals with comorbid conditions. Significant vaccine hesitancy was found, and early self-reported side effect experiences among those who had already been vaccinated may help alleviate vaccine fears. Health care-related social media forums may play an important role in disseminating accurate information about COVID-19 vaccines.

JMIR PUBLIC HEALTH AND SURVEILLANCE (2022)

Article Oncology

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

David J. Pinato et al.

Summary: This study provides evidence to support the beneficial effect of SARS-CoV-2 vaccines against morbidity and mortality from COVID-19 in patients with cancer.

EUROPEAN JOURNAL OF CANCER (2022)

Article Oncology

Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population- based test-negative case-control study

Lennard Y. W. Lee et al.

Summary: This study evaluated the effectiveness of vaccines against breakthrough SARS-CoV-2 infections in patients with cancer. The results showed that the effectiveness of vaccines in cancer patients is lower compared to the general population.

LANCET ONCOLOGY (2022)

Article Oncology

Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients

Nesrine Mejri et al.

Summary: The study found that factors like educational level, history of comorbidities, history of influenza vaccination, and patient's opinion about COVID-19 severity did not predict vaccine resistance. However, patients who thought the vaccine may interfere with treatment efficacy or cancer outcome were more likely to refuse the vaccine. Patients who disagreed that the vaccine is a major weapon against the pandemic or could reduce virus transmission were also more likely to reject vaccination. Safety concerns and confidence in authorities were also significant predictive factors.

SUPPORTIVE CARE IN CANCER (2022)

Review Oncology

Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta-analysis of cohort studies

Aakash Desai et al.

Summary: The analysis of 2922 cancer patients with COVID-19 from primarily inpatient studies showed a 30-day mortality rate of 30%, while the overall rate was 15% among 624 patients from studies including both inpatient and outpatient populations. Factors such as male sex, older age, cancer subtype, and recent active cancer therapy partially explained the heterogeneity in mortality reporting, with male sex and an interaction between patient age and recent therapy accounting for most of the variance in mortality rates between studies.

CANCER (2021)

Article Oncology

COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective

Marie Forster et al.

Summary: Breast and gynecologic cancer patients undergoing systemic cancer therapy can tolerate COVID-19 vaccination without additional side effects. The COVID-19 vaccines had an acceptable safety profile with self-limiting adverse events, predominantly occurring after the second dose and less frequently in older patients. Vaccination had limited effects on the therapy schedule and no serious adverse events were reported.

BREAST (2021)

Article Oncology

Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data

Nuriye Ozdemir et al.

Summary: This study examined patients with solid malignancies and COVID-19 in Turkey, finding that older age, male gender, presence of diabetes, receipt of cytotoxic therapy, and certain abnormal laboratory parameters were associated with increased 30-day mortality, while breast and prostate cancer diagnoses were associated with lower 30-day mortality. The relatively lower mortality compared to Western countries and China may be due to baseline risk factors and the importance of intensive supportive care.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Oncology

Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited

Antoni Ribas et al.

Summary: Patients with cancer, especially those with hematologic malignancies, are considered among the very high-risk groups for priority COVID-19 vaccination due to the confluence of risk factors between cancer and the virus, which may increase exposure and suppress immune responses.

CANCER DISCOVERY (2021)

Article Biotechnology & Applied Microbiology

Influenza vaccination uptake and attitudes among adult cancer patients in Japan: a web-based questionnaire survey before the 2020/2021 season

Makoto Kosaka et al.

Summary: This study found that influenza vaccination coverage among adult Japanese cancer patients was relatively low, with factors such as vaccination history and perception of importance due to the COVID-19 pandemic influencing positive intention towards vaccination.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Immunology

Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study

Xiaozhen Lai et al.

Summary: Public acceptance of COVID-19 booster vaccination is relatively high in China, with concerns primarily focused on vaccine safety. Factors influencing acceptance include vaccination history, perceived benefits and barriers, age, education level, employment status, and belonging to priority vaccination groups.

VACCINES (2021)

Article Medicine, General & Internal

Prevalence and Impact Factors of COVID-19 Vaccination Hesitancy Among Breast Cancer Survivors: A Multicenter Cross-Sectional Study in China

Xin Peng et al.

Summary: Cancer patients, particularly breast cancer survivors, face high risk of COVID-19 infection but have low vaccination rates. Factors contributing to vaccination hesitancy included current treatment, lack of information, and influence of healthcare providers. Effective communication, clear vaccination guidelines, and timely information dissemination could help combat vaccine hesitancy among this population.

FRONTIERS IN MEDICINE (2021)

Article Immunology

Attitudes of Patients with Cancer towards Vaccinations-Results of Online Survey with Special Focus on the Vaccination against COVID-19

Anna Brodziak et al.

Summary: Most Polish cancer patients have a positive attitude towards COVID-19 vaccination, but express concerns about safety, effectiveness, and the development process of the vaccine. Key factors influencing willingness to vaccinate include education level, marital status, and positive attitude towards vaccinations.

VACCINES (2021)

Review Oncology

Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis

Marco Tagliamento et al.

Summary: A systematic review and meta-analysis found that adult patients with solid or hematological malignancies and SARS-CoV-2 infection have a high probability of mortality, with lung cancer patients having a higher case fatality rate (CFR) and breast cancer patients having a lower CFR.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Article Public, Environmental & Occupational Health

Changing emotions in the COVID-19 pandemic: A four-wave longitudinal study in the United States and China*

Ying Li et al.

Summary: The study found that people's emotional reactions during the different stages of the COVID-19 pandemic did not directly correlate with infection and death rates, but instead quickly returned to normal. Preventive behaviors were influenced by fear, anxiety, and worry at the onset of the viral outbreak, while actively acquiring information about COVID-19 had a more lasting impact on engagement in preventive behaviors.

SOCIAL SCIENCE & MEDICINE (2021)

Article Oncology

Cancer Patients' Willingness to Take COVID-19 Vaccination: A Nationwide Multicenter Survey in Korea

June Young Chun et al.

Summary: Despite the importance of COVID-19 vaccination in cancer patients, overall vaccine uptake rates are low. Factors such as disease status, health status, and physician recommendations were found to be associated with higher acceptance rates of vaccination. Physicians play a crucial role in influencing cancer patients' decisions regarding COVID-19 vaccines.

CANCERS (2021)

Article Immunology

Vaccine Acceptance and Its Influencing Factors: An Online Cross-Sectional Study among International College Students Studying in China

Anita Nyarkoa Walker et al.

Summary: The study found that the acceptance of the COVID-19 vaccine among international students was low, with cues to action, perception of vaccine benefits, and barriers associated with acceptance. It is crucial to raise correct beliefs about the vaccine among the target group and adopt social strategies to trigger their intention to get vaccinated.

VACCINES (2021)

Editorial Material Oncology

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Wenhua Liang et al.

LANCET ONCOLOGY (2020)

Editorial Material Oncology

COVID-19 and cancer: what we know so far

Peter Sidaway

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Review Immunology

Vaccination in the elderly: The challenge of immune changes with aging

Annalisa Ciabattini et al.

SEMINARS IN IMMUNOLOGY (2018)

Article Public, Environmental & Occupational Health

Beliefs and attitudes towards the influenza vaccine in high-risk individuals

A. J. Santos et al.

EPIDEMIOLOGY AND INFECTION (2017)

Article Immunology

Vaccine hesitancy: Definition, scope and determinants

Noni E. MacDonald

VACCINE (2015)

Article Infectious Diseases

Factors associated with influenza vaccination among adult cancer patients: a case-control study

I. Vinograd et al.

CLINICAL MICROBIOLOGY AND INFECTION (2014)

Article Public, Environmental & Occupational Health

Health Belief Model applied to non-compliance with HPV vaccine among female university students

E. M. Donadiki et al.

PUBLIC HEALTH (2014)